SBS-30 Sleep Management helps increase length and duration of sleep.
We have carried out studies to evaluate the effectiveness of the patches to help increase the length and duration of sleep in people suffering with sleep disorders.
OBJECTIVES: To investigate if 3 months of 2 types of non-transdermal patches in subjects with sleep issues improved their quality and length of nightly sleep and decreased their daytime sleepiness.
DESIGN, SETTING, AND PARTICIPANTS: 50 subjects with chronic insomnia for a minimum of over three months, between ages of 18 and 80. Eligible subjects were randomized to receive treatment with SBS or a placebo for the first two-weeks. All subjects received SBS for an additional 4 weeks. Three validated sleep scales were used to measure daytime sleepiness and length of sleep at baseline and then at the end of the two-week placebo period and again at the end of the study.
MAIN OUTCOMES AND MEASURES: Those receiving active patches entered with 3.9 hours average length of sleep. At the end of the first 2 weeks, they were sleeping an average of 6.1 hours and after another 4 weeks they were sleeping an average of 6.2 hours. Those who initially received placebo patches entered sleeping an average of 3.6 hours. At the end of the first two weeks, they averaged 4.6 hours and after 4 weeks using the active patches, they averaged 6 hours of sleep.
OBJECTIVES: To investigate if 30 nights use of SBS patches in subjects with self-assessed sleep difficulties measured changes in their sleep with sleep scales and questionnaires.
DESIGN, SETTING, AND PARTICIPANTS: Individuals were instructed to place one of the patches on 1 of 5 specific acupuncture points at bedtime. If individuals did not sleep adequately, on the next night they would move the patch to another point until they found a placement that achieved the best possible sleep. Once they found a point that worked, they would continue using the patch on that point on successive nights.
MAIN OUTCOMES AND MEASURES: There were no adverse events reported in the group. Results from the self-assessed sleep study showed, 72% of the individuals had normal daytime sleepiness on the Epworth Sleepiness Scale (ESS Test); 80% noted improved quality of sleep on the Leeds Sleep Evaluation Questionnaire (LESQ Test); 88% had improved length of sleep on the Pittsburgh Sleep Quality Index (PSQ Test).
SBDV-40 for Supportive Care give peoples added support through their journey of recovery of cancer treatments.
Review the below third-party study on acupressure treatment to reduce fatigue, improve sleep and quality of life in people who have recently undergone treatment for breast cancer.